-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Lexaria Bioscience, Lowers Price Target to $5

Benzinga·07/01/2025 11:40:29
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and lowers the price target from $7 to $5.